Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Current Assets:    
Cash and cash equivalents $ 17,787,159 $ 20,952,867
Restricted certificate of deposit 250,375 251,236
Short-term investments 4,959,263
Accounts receivable, net 1,622,434 794,136
Inventories 6,666,912
Contract assets 573,895 893,375
Prepaid insurance 2,392,978 67,219
Other Current assets 2,710,031 210,225
Total Current assets 36,963,047 23,169,058
Property and equipment, net 15,167,367 1,437,311
Operating lease right-of-use asset 317,208 513,763
Other assets 155,490 47,240
Total assets 52,603,112 25,167,372
Current Liabilities:    
Accounts payable 324,484 1,402,424
Accrued liabilities 3,142,977 1,576,433
Operating lease liabilities - current 410,158 353,598
Notes payable - current 10,250,000
Notes payable, related parties - current 3,000,000
Total Current Liabilities 3,877,619 16,582,455
Warrant liabilities 32,688,342
Operating lease liabilities - long-term 87,214 467,208
Notes payable - long-term, net of discount 15,922,118 14,708,333
Other liabilities 20,833
Total Liabilities 52,575,293 31,778,829
Commitments and Contingencies
Stockholders’ Equity (Deficit):    
Preferred stock, $0.0001 par value; 10,000,000 shares, authorized
Series A preferred stock, $0.01 par value; 0 and 334,800 shares, respectively, issued, and outstanding 3,348
Series B preferred stock, $0.01 par value; 0 and 725,426 shares, respectively, issued, and outstanding 7,254
Common stock, $0.0001 par value; 625,000,000 shares authorized, 47,250,771 and 9,669,217 shares issued, respectively, and 47,250,771 and 9,669,217 shares outstanding, respectively 4,725 967
Additional paid-in capital 68,128,196 33,221,505
Accumulated deficit (68,105,102) (39,844,531)
Total Stockholders’ Equity (Deficit) 27,819 (6,611,457)
Total Liabilities and Stockholders’ Equity (Deficit) $ 52,603,112 $ 25,167,372